ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,614Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 337

$358K Total Retail Price of All Prescriptions

Rank: 127 out of 337

414 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 414 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 414 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,341 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 599 516 1 2
HYDROCHLOROTHIAZIDE 462 441 2 9
ATENOLOL 392 341 3 10
AMLODIPINE BESYLATE 366 332 4 3
ATORVASTATIN CALCIUM 322 246 5 7
OMEPRAZOLE 317 275 6 4
SIMVASTATIN 315 289 7 1
LOSARTAN POTASSIUM 260 230 8 15
LEVOTHYROXINE SODIUM 230 203 9 5
RANITIDINE HCL 178 172 10 30
METFORMIN HCL 168 146 11 12
CITALOPRAM HBR 161 147 12 17
HYDROCODONE-ACETAMINOPHEN 153 89 S3 13 13
SERTRALINE HCL 137 117 14 18
TRAZODONE HCL 127 104 15 16
GABAPENTIN 118 89 16 20
FUROSEMIDE 115 111 17 8
METOPROLOL TARTRATE 115 111 17 6
NIFEDIPINE ER 106 92 19 111
PRAVASTATIN SODIUM 105 94 20 14
DIOVAN 95 91 21 26
ZOLPIDEM TARTRATE 95 84 21 23
LIPITOR 83 83 23 33
FLUTICASONE PROPIONATE 75 66 24 34
OXYCODONE HCL 75 50 S2 24 63
KLOR-CON M20 75 74 24 65
WARFARIN SODIUM 70 70 27 11
SYNTHROID 67 66 28 41
PREDNISONE 67 47 28 40
ALENDRONATE SODIUM 66 53 30 19
DILTIAZEM 24HR ER 65 65 31 76
PANTOPRAZOLE SODIUM 64 56 32 36
MIRTAZAPINE 63 48 33 27
GLIPIZIDE 63 48 33 45
ADVAIR DISKUS 61 31 35 44
LOVASTATIN 60 60 36 24
COLCRYS 58 58 37 128
FLUOXETINE HCL 56 42 38 57
PAROXETINE HCL 52 41 39 46
NEXIUM 51 45 40 56
FLOVENT HFA 51 50 40 155
ISOSORBIDE MONONITRATE ER 50 46 42 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.